Sagimet Biosciences SGMT Ratios (2022-2026)

NASDAQ SGMT
$9.33 -0.61 (-6.14%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

Sagimet Biosciences Quarterly Ratios

Periods 16 quarters
Latest Jun 2026

Sagimet Biosciences ratios data for the quarter ended Jun 2026. These financial ratios cover 16 quarters of results from Sep 2022 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Ratios Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Profitability
EBT Margin -317.85%
EBIT Margin -372.60%
Operating Margin -372.60%
Net Margin -317.65%
FCF Margin -193.95%
Efficiency
Assets AverageAssets Avg. 62.21M99.82M145.62M191.77M181.90M167.52M153.22M141.79M132.90M122.44M112.12M185.59M
Equity AverageEquity Avg. -176.99M-183.75M-189.82M-195.56M-50.27M94.47M140.54M186.66M176.99M163.24M147.40M134.58M124.71M115.32M106.92M179.31M
Valuation
Price to BookP/B 2.061.360.830.600.520.910.761.881.871.721.661.60
Enterprise Value 99.64M29.20M-36.31M-57.23M-63.45M-10.17M-39.61M119.92M106.02M78.36M65.42M170.45M
Market Capitalization 201.48M124.10M157.39M109.15M89.04M141.08M104.96M245.33M222.71M191.49M169.96M410.58M
Return Ratios
Return on Sales [ROS]ROS -372.60%
Return on Capital Employed [ROCE]ROCE -50.14%-32.64%-33.39%-49.71%-51.97%-48.48%-45.62%-29.21%
Return on Assets [ROA]ROA -43.27%-27.93%-19.17%-15.26%-20.63%-27.20%-37.28%-41.88%-43.39%-41.68%-38.81%-25.37%
Return on Equity [ROE]ROE -29.51%-19.87%-15.67%-21.20%-27.91%-38.75%-44.13%-46.25%-44.26%-40.70%-26.26%

Sagimet Biosciences Ratios API

Pull Sagimet Biosciences's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=SGMT&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY